4th Annual MCLE-a-thon: Federal Funding & Legal Landmines: A Guide for In‑House Teams
As part of the firm’s 4th annual MCLE‑a‑thon, Lance D. Smemoe provides a practical overview of the intellectual property risks associated with federal funding and government contracts. Lance discusses how...
4th Annual MCLE-a-thon: Multifaceted Discrimination in the Legal Community: Intersectionality of Gender, Race, Ethnicity, and Sexual Orientation
As part of the firm’s 4th annual MCLE‑a‑thon, partner Jeff Van Hoosear and Chief Diversity & Talent Development Officer Terra Davis examine the concept of intersectionality and its impact within...
FDA Issues Recommendations for the Development of Individualized Therapies for Patients With Ultra-Rare Diseases
Key Takeaway: The FDA is developing a “plausible mechanism framework” to facilitate approval of individualized therapies for the treatment of rare genetic diseases that currently face approval challenges. As discussed previously...